Next Article in Journal
Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases
Next Article in Special Issue
Aging Risk and Health Care Expenditure in Korea
Previous Article in Journal
Lime-Based Sorbents for High-Temperature CO2 Capture—A Review of Sorbent Modification Methods
Previous Article in Special Issue
Promotion of Physical Activity Using Point-of-Decision Prompts in Berlin Underground Stations
Article Menu

Export Article

Open AccessArticle
Int. J. Environ. Res. Public Health 2010, 7(8), 3141-3149; doi:10.3390/ijerph7083141

The Global Challenge of Antimicrobial Resistance: Insights from Economic Analysis

1
Shorenstein Asia-Pacific Research Center, Stanford University, 616 Serra Road, Encina Hall, Stanford, CA 94305, USA
2
Global Investment Research, Goldman Sachs International, Peterborough Court, 133 Fleet Street, London EC4A 2BB, UK
3
John F. Kennedy School of Government, Harvard University, 79 John F. Kennedy Street, Cambridge, MA 02138, USA
*
Author to whom correspondence should be addressed.
Received: 24 June 2010 / Revised: 27 July 2010 / Accepted: 30 July 2010 / Published: 9 August 2010
(This article belongs to the Special Issue Health Behavior and Public Health)
View Full-Text   |   Download PDF [152 KB, uploaded 19 June 2014]   |  

Abstract

The prevalence of antimicrobial resistance (AR) limits the therapeutic options for treatment of infections, and increases the social benefit from disease prevention. Like an environmental resource, antimicrobials require stewardship. The effectiveness of an antimicrobial agent is a global public good. We argue for greater use of economic analysis as an input to policy discussion about AR, including for understanding the incentives underlying health behaviors that spawn AR, and to supplement other methods of tracing the evolution of AR internationally. We also discuss integrating antimicrobial stewardship into global health governance.The prevalence of antimicrobial resistance (AR) limits the therapeutic options for treatment of infections, and increases the social benefit from disease prevention. Like an environmental resource, antimicrobials require stewardship. The effectiveness of an antimicrobial agent is a global public good. We argue for greater use of economic analysis as an input to policy discussion about AR, including for understanding the incentives underlying health behaviors that spawn AR, and to supplement other methods of tracing the evolution of AR internationally. We also discuss integrating antimicrobial stewardship into global health governance. View Full-Text
Keywords: antimicrobial resistance; economic analysis; drug resistance; behavioral economics antimicrobial resistance; economic analysis; drug resistance; behavioral economics
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Eggleston, K.; Zhang, R.; Zeckhauser, R.J. The Global Challenge of Antimicrobial Resistance: Insights from Economic Analysis. Int. J. Environ. Res. Public Health 2010, 7, 3141-3149.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top